Resultados: 6

Optimizing the immunogenicity of HIV prime-boost DNA-MVA-rgp140/GLA vaccines in a phase II randomized factorial trial design

PLos ONE; 13 (11), 2018
Background: We evaluated the safety and immunogenicity of (i) an intradermal HIV-DNA regimen given with/without intradermal electroporation (EP) as prime and (ii) the impact of boosting with modified vaccinia virus Ankara (HIV-MVA) administered with or without subtype C CN54rgp140 envelope protein adjuva...

Performance Evaluation of the MyT4 Technology for Determining ART Eligibility

PLos ONE; 11 (10), 2016
Background In resource-limited countries, CD4 T-cell (CD4) testing continues to be used for determining antiretroviral therapy (ART) initiation eligibility and opportunistic infection monitoring. To support expanded access to CD4 testing, simple and robust technologies are necessary. We conducted this st...

Perfil imunológico, virológico e expressão de CD38 pelas células TCD8 dos pacientes HIV-1 positivos e coinfectados HIV/TB seguidos no Centro de Saúde da Polana Caniço

Segundo OMS, em 2013 aproximadamente 35 milhões de pessoas no Mundo estavam infectadas pelo HIV e destes, aproximadamente 24,7 milhões viviam na África Subsaariana. Em Moçambique, a prevalência é de 11,5% na população com 15-49 anos de idade. O aumento da prevalência do HIV na década de 80, pro...

Co-infection by human immunodeficiency virus type 1 (HIV-1) and human T cell leukemia virus type 1 (HTLV-1): does immune activation lead to a faster progression to AIDS?

BMC infect. dis; 9 (221), 2009
Background: Recent data have shown that HTLV-1 is prevalent among HIV positive patients in Mozambique, although the impact of HTLV-1 infection on HIV disease progression remains controversial. Our aim was to determine the phenotypic profile of T lymphocytes subsets among Mozambican patients co-infected b...

Assessment of routine surveillance data as a tool to investigate measles outbreaks in Mozambique

BMC infect. dis; 6 (29), 2006
Background: Measles remains a major public health problem in Mozambique despite significant efforts to control the disease. Currently, health authorities base their outbreak control on data from the routine surveillance system while vaccine coverage and efficacy are calculated based on mathematical proje...